Literature DB >> 776394

Precursor lesions for liver cancer in humans.

P P Anthony.   

Abstract

Our knowledge of the cellular changes that lead to liver cell carcinoma in humans is limited by proper and necessary ethical restriction on clinical research. We know rather more about risk factors, the most important of which is cirrhosis, it seems that both the causative agent and the time of duration of the cirrhotic process are relevent to the magnitude of this risk. According to present knowledge, alpha1-antitrypsin deficiency, alcoholism, naturally occurring carcinogens, drugs, and the hepatitis B virus seem to carry the greatest risk of cancer developing in a cirrhotic patient. Cirrhosis, however, is not an essential prerequisite, and some or possibly all of these agents can also induce cancer without cirrhosis. Bile duct carcinoma commonly follows infestation with liver flukes. Cirrhosis is usually absent but duct epithelial hyperplasia is present prior to the development of cancer. Many cellular changes have been observed in patients and among populations considered to be at risk from liver cancer. Of these, liver cell dysplasia is the most striking and studies of its prevalence, natural history, and association with cirrhosis suggest that it is a precancerous change.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 776394

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Cytophotometric DNA analysis of adenomatous hyperplasia in cirrhotic livers.

Authors:  M Hoso; Y Nakanuma
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Comparison of the proliferative capacity of adenomatous hyperplasia and well differentiated hepatocellular carcinoma.

Authors:  A Yamashita
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

Review 3.  Screening for hepatocellular carcinoma. Review and perspective.

Authors:  J C Ellis
Journal:  West J Med       Date:  1988-08

Review 4.  Pathologic aspects of cirrhosis. A review.

Authors:  H Popper
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

5.  Abnormal sex-steroid milieu in young adults with hepatocellular carcinoma.

Authors:  R A Malt; J J Galdabini; B W Jeppsson
Journal:  World J Surg       Date:  1983-03       Impact factor: 3.352

6.  Morphological clues for the diagnosis of small hepatocellular carcinomas.

Authors:  F Kondo; N Hirooka; K Wada; Y Kondo
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

7.  Immunohistochemical expression of components of the Akt-mTORC1 pathway is associated with hepatocellular carcinoma in patients with chronic liver disease.

Authors:  Scott J Cotler; Nissim Hay; Hui Xie; Mei Ling Chen; Pei Zhang Xu; Thomas J Layden; Grace Guzman
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

8.  Morphometric study of hepatocytes containing hepatitis B surface antigen.

Authors:  M L Chen; M A Gerber; S N Thung; J C Thornton; W K Chung
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

9.  A case report of hepatocellular carcinoma within adenomatous hyperplasia: is adenomatous hyperplasia a precancerous lesion or not?

Authors:  A Itoh; H Taniguchi; K Sawai; T Takahashi; K Kawamoto; T Deguchi; K Kagawa
Journal:  Gastroenterol Jpn       Date:  1991-08

10.  Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma.

Authors:  M Zhao; N X Zhang; J A Laissue; A Zimmermann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.